Companies/US/ODTX

ODYSSEY THERAPEUTICS, INC.

Last · NASDAQ$16.60-0.64 (-3.71%)close · yahoo · 16h ago
Vol 245.6K ≈ 4.08M
Market cap$797.77M48.1M sh
P/E · TTM-2.3fwd -4.0 · eps -7.29 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$15.10$29.05
Volume245.6Ksession

Issuer

Legal nameODYSSEY THERAPEUTICS, INC.
HQUnited States (US)
ListingUS ODTX
ISINUS67613T1043
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001882782
CIK0001882782
Websitewww.odysseytx.com
Employees100
AddressOdyssey Therapeutics, Inc. 51 Sleeper Street 02210, Boston
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.96
Est. revenue
0
View upcoming earnings →

Press & signals

2 recent
  • GlobeNewswire

    Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  • GlobeNewswire

    Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Documents

FormReporting forFiledFlags
8-KCurrent Report (8-K)
—2026-09-090
10-Q
2026-06-302026-08-06 4
8-K8-K: Results of Operations and Financial Condition
2026-08-042026-08-040
8-K8-K: Regulation FD Disclosure
2026-06-232026-06-230
8-K8-K: Results of Operations and Financial Condition
2026-06-172026-06-170
Showing 5 of 6 filings